Efficacy of tenofovir-based rescue therapy for chronic hepatitis B patients with resistance to lamivudine and entecavir
Hee-Jeong Jeon, Seok Won Jung, Neung Hwa Park, Yujin Yang, Jin-Hee Noh, Jae-Sung Ahn, Hyung Rae Kim, Jae Ho Lee, Jung Woo Shin
Clin Mol Hepatol. 2017;23(3):230-238.   Published online 2017 Jun 30     DOI: https://doi.org/10.3350/cmh.2017.0003
Citations to this article as recorded by Crossref logo
Bilateral atraumatic neck of femur fractures secondary to tenofovir-induced fanconi syndrome
Vikaesh Moorthy, Kelvin Guoping Tan
Journal of Orthopaedic Reports.2023; 2(1): 100123.     CrossRef
Molecular characterization of hepatitis B virus (HBV) isolated from a pediatric case of acute lymphoid leukemia, with a delayed response to antiviral treatment: a case report
Chien-Yu Chen, Christina Hajinicolaou, Priya Walabh, Luicer Anne Olubayo Ingasia, Ernest Song, Anna Kramvis
BMC Pediatrics.2022;[Epub]     CrossRef
Tenofovir Alafenamide Fumarate, Tenofovir Disoproxil Fumarate and Entecavir: Which is the Most Effective Drug for Chronic Hepatitis B? A Systematic Review and Meta-analysis
Xuefeng Ma, Shousheng Liu, Mengke Wang, Yifen Wang, Shuixian Du, Yongning Xin, Shiying Xuan
Journal of Clinical and Translational Hepatology.2021; 000(000): 000.     CrossRef
Asociación Mexicana de Hepatología A.C. Clinical guideline on hepatitis B
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñ
Revista de Gastroenterología de México (English Edition).2021; 86(4): 403.     CrossRef
Asociación Mexicana de Hepatología A.C. Guía Clínica de Hepatitis B
F. Higuera-de-la-Tijera, G.E. Castro-Narro, J.A. Velarde-Ruiz Velasco, E. Cerda-Reyes, R. Moreno-Alcántar, I. Aiza-Haddad, M. Castillo-Barradas, L.E. Cisneros-Garza, M. Dehesa-Violante, J. Flores-Calderón, M.S. González-Huezo, E. Márquez-Guillén, L.E. Muñ
Revista de Gastroenterología de México.2021; 86(4): 403.     CrossRef
Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response
Hyun Young Woo, Jun Yong Park, Si Hyun Bae, Chang Wook Kim, Jae Young Jang, Won Young Tak, Dong Joon Kim, In Hee Kim, Jeong Heo, Sang Hoon Ahn
Clinical and Molecular Hepatology.2020; 26(3): 352.     CrossRef
Tenofovir‐based combination therapy or monotherapy for multidrug‐resistant chronic hepatitis B: Long‐term data from a multicenter cohort study
Hyung Joon Yim, Sang Jun Suh, Young Kul Jung, Seong Gyu Hwang, Yeon Seok Seo, Soon Ho Um, Sae Hwan Lee, Young Seok Kim, Jae Young Jang, In Hee Kim, Hyoung Su Kim, Ji Hoon Kim, Young Sun Lee, Eileen L. Yoon, Myeong Jun Song, Jun Yong Park
Journal of Viral Hepatitis.2020; 27(12): 1306.     CrossRef
Efficacy and cost-effectiveness of antiviral regimens for entecavir-resistant hepatitis B: A systematic review and network meta-analysis
Si-Si Yang, Cheng-Wei Cai, Xue-Qing Ma, Jia Xu, Cheng-Bo Yu
Hepatobiliary & Pancreatic Diseases International.2020; 19(6): 507.     CrossRef
Long-term Efficacy of Tenofovir Disoproxil Fumarate Monotherapy for Multidrug-Resistant Chronic HBV infection
Hye Won Lee, Jun Yong Park, Jin Woo Lee, Ki Tae Yoon, Chang Wook Kim, Hana Park, Young Seok Kim, Soon Ku Paik, Jung Il Lee, Beom Kyung Kim, Kwang-Hyub Han, Sang Hoon Ahn
Clinical Gastroenterology and Hepatology.2019; 17(7): 1348.     CrossRef
Risk factors associated with hypophosphatemia in chronic Hepatitis B patients treated with tenofovir disoproxil fumarate
Dohyeong Lee, Byung Cheol Yun, Kwang Il Seo, Byung Hoon Han, Sang Uk Lee, Eun Taek Park, Jin Wook Lee, Joonho Jeong
Medicine.2019; 98(50): e18351.     CrossRef
Effect of tenofovir on renal function in patients with chronic hepatitis B
Woo Jin Jung, Jae Young Jang, Won Young Park, Soung Won Jeong, Hee Jeong Lee, Sang Joon Park, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Baigal Baymbajav
Medicine.2018; 97(7): e9756.     CrossRef
Long-term Outcomes in Patients with HBV Treated with Antiviral Agents
Mauro Viganò, Alessandro Loglio, Pietro Lampertico
Current Hepatology Reports.2018; 17(4): 502.     CrossRef
Is tenofovir monotherapy a sufficient defense line against multi-drug resistant hepatitis B virus?
Yun Bin Lee, Jeong-Hoon Lee
Clinical and Molecular Hepatology.2017; 23(3): 219.     CrossRef